188 related articles for article (PubMed ID: 19513025)
21. Negative lymph node count is associated with survival of colorectal cancer patients, independent of tumoral molecular alterations and lymphocytic reaction.
Ogino S; Nosho K; Irahara N; Shima K; Baba Y; Kirkner GJ; Mino-Kenudson M; Giovannucci EL; Meyerhardt JA; Fuchs CS
Am J Gastroenterol; 2010 Feb; 105(2):420-33. PubMed ID: 19809407
[TBL] [Abstract][Full Text] [Related]
22. Relationship of CDX2 loss with molecular features and prognosis in colorectal cancer.
Baba Y; Nosho K; Shima K; Freed E; Irahara N; Philips J; Meyerhardt JA; Hornick JL; Shivdasani RA; Fuchs CS; Ogino S
Clin Cancer Res; 2009 Jul; 15(14):4665-73. PubMed ID: 19584150
[TBL] [Abstract][Full Text] [Related]
23. CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer.
Ogino S; Nosho K; Kirkner GJ; Kawasaki T; Meyerhardt JA; Loda M; Giovannucci EL; Fuchs CS
Gut; 2009 Jan; 58(1):90-6. PubMed ID: 18832519
[TBL] [Abstract][Full Text] [Related]
24. PIK3CA mutation is associated with poor prognosis among patients with curatively resected colon cancer.
Ogino S; Nosho K; Kirkner GJ; Shima K; Irahara N; Kure S; Chan AT; Engelman JA; Kraft P; Cantley LC; Giovannucci EL; Fuchs CS
J Clin Oncol; 2009 Mar; 27(9):1477-84. PubMed ID: 19237633
[TBL] [Abstract][Full Text] [Related]
25. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis.
Mima K; Nishihara R; Qian ZR; Cao Y; Sukawa Y; Nowak JA; Yang J; Dou R; Masugi Y; Song M; Kostic AD; Giannakis M; Bullman S; Milner DA; Baba H; Giovannucci EL; Garraway LA; Freeman GJ; Dranoff G; Garrett WS; Huttenhower C; Meyerson M; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S
Gut; 2016 Dec; 65(12):1973-1980. PubMed ID: 26311717
[TBL] [Abstract][Full Text] [Related]
26. Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas.
Karst AM; Levanon K; Duraisamy S; Liu JF; Hirsch MS; Hecht JL; Drapkin R
Gynecol Oncol; 2011 Oct; 123(1):5-12. PubMed ID: 21683992
[TBL] [Abstract][Full Text] [Related]
27. STAT3 expression, molecular features, inflammation patterns, and prognosis in a database of 724 colorectal cancers.
Morikawa T; Baba Y; Yamauchi M; Kuchiba A; Nosho K; Shima K; Tanaka N; Huttenhower C; Frank DA; Fuchs CS; Ogino S
Clin Cancer Res; 2011 Mar; 17(6):1452-62. PubMed ID: 21310826
[TBL] [Abstract][Full Text] [Related]
28. Tumor expression of calcium sensing receptor and colorectal cancer survival: Results from the nurses' health study and health professionals follow-up study.
Momen-Heravi F; Masugi Y; Qian ZR; Nishihara R; Liu L; Smith-Warner SA; Keum N; Zhang L; Tchrakian N; Nowak JA; Yang W; Ma Y; Bowden M; da Silva A; Wang M; Fuchs CS; Meyerhardt JA; Ng K; Wu K; Giovannucci E; Ogino S; Zhang X
Int J Cancer; 2017 Dec; 141(12):2471-2479. PubMed ID: 28856682
[TBL] [Abstract][Full Text] [Related]
29. DNMT3B expression might contribute to CpG island methylator phenotype in colorectal cancer.
Nosho K; Shima K; Irahara N; Kure S; Baba Y; Kirkner GJ; Chen L; Gokhale S; Hazra A; Spiegelman D; Giovannucci EL; Jaenisch R; Fuchs CS; Ogino S
Clin Cancer Res; 2009 Jun; 15(11):3663-71. PubMed ID: 19470733
[TBL] [Abstract][Full Text] [Related]
30. STMN1 in colon cancer: expression and prognosis in Chinese patients.
Zhang HQ; Guo X; Guo SQ; Wang Q; Chen XQ; Li XN; Guo LS
Eur Rev Med Pharmacol Sci; 2016 May; 20(10):2038-44. PubMed ID: 27249602
[TBL] [Abstract][Full Text] [Related]
31. Cyclooxygenase-2 expression is an independent predictor of poor prognosis in colon cancer.
Ogino S; Kirkner GJ; Nosho K; Irahara N; Kure S; Shima K; Hazra A; Chan AT; Dehari R; Giovannucci EL; Fuchs CS
Clin Cancer Res; 2008 Dec; 14(24):8221-7. PubMed ID: 19088039
[TBL] [Abstract][Full Text] [Related]
32. Down-regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer.
Ogino S; Kawasaki T; Kirkner GJ; Ogawa A; Dorfman I; Loda M; Fuchs CS
J Pathol; 2006 Oct; 210(2):147-54. PubMed ID: 16850502
[TBL] [Abstract][Full Text] [Related]
33. Cytoplasmic localization of p27 (cyclin-dependent kinase inhibitor 1B/KIP1) in colorectal cancer: inverse correlations with nuclear p27 loss, microsatellite instability, and CpG island methylator phenotype.
Ogino S; Kawasaki T; Ogawa A; Kirkner GJ; Loda M; Fuchs CS
Hum Pathol; 2007 Apr; 38(4):585-92. PubMed ID: 17239930
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer.
Baba Y; Nosho K; Shima K; Meyerhardt JA; Chan AT; Engelman JA; Cantley LC; Loda M; Giovannucci E; Fuchs CS; Ogino S
Br J Cancer; 2010 Sep; 103(7):1025-33. PubMed ID: 20808308
[TBL] [Abstract][Full Text] [Related]
35. JC virus T-antigen in colorectal cancer is associated with p53 expression and chromosomal instability, independent of CpG island methylator phenotype.
Nosho K; Shima K; Kure S; Irahara N; Baba Y; Chen L; Kirkner GJ; Fuchs CS; Ogino S
Neoplasia; 2009 Jan; 11(1):87-95. PubMed ID: 19107235
[TBL] [Abstract][Full Text] [Related]
36. Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: Prognostic implications and response to chemotherapy.
Murcia O; Juárez M; Rodríguez-Soler M; Hernández-Illán E; Giner-Calabuig M; Alustiza M; Egoavil C; Castillejo A; Alenda C; Barberá V; Mangas-Sanjuan C; Yuste A; Bujanda L; Clofent J; Andreu M; Castells A; Llor X; Zapater P; Jover R
PLoS One; 2018; 13(9):e0203051. PubMed ID: 30188916
[TBL] [Abstract][Full Text] [Related]
37. CHFR promoter methylation indicates poor prognosis in stage II microsatellite stable colorectal cancer.
Cleven AH; Derks S; Draht MX; Smits KM; Melotte V; Van Neste L; Tournier B; Jooste V; Chapusot C; Weijenberg MP; Herman JG; de Bruïne AP; van Engeland M
Clin Cancer Res; 2014 Jun; 20(12):3261-71. PubMed ID: 24928946
[TBL] [Abstract][Full Text] [Related]
38. Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors.
Baba Y; Huttenhower C; Nosho K; Tanaka N; Shima K; Hazra A; Schernhammer ES; Hunter DJ; Giovannucci EL; Fuchs CS; Ogino S
Mol Cancer; 2010 May; 9():125. PubMed ID: 20507599
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample.
Nosho K; Irahara N; Shima K; Kure S; Kirkner GJ; Schernhammer ES; Hazra A; Hunter DJ; Quackenbush J; Spiegelman D; Giovannucci EL; Fuchs CS; Ogino S
PLoS One; 2008; 3(11):e3698. PubMed ID: 19002263
[TBL] [Abstract][Full Text] [Related]
40. The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancer.
Hemdan T; Lindén M; Lind SB; Namuduri AV; Sjöstedt E; de Ståhl TD; Asplund A; Malmström PU; Segersten U
Br J Cancer; 2014 Sep; 111(6):1180-7. PubMed ID: 25072257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]